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An evaluation of the development of experimental membranous
nephropathy. Heymann nephritis is a rat model of glomerulonephritis
with morphologic manifestations of human membranous nephropathy.
This model is generated by immunizing rats with FxIA antigen. Passive
Heymann's nephritis (PHN) can be produced by the administration of
anti-Fx1A antibody (anti-Fx1A Ab) (with abnormal proteinuria appear-
ing in 5 days). Studies were designed to examine the evolution of
temporal changes in protein excretion, the glomerular ultrafiltration
coefficient (LpA) and morphology of glomerular capillary three and five
days after induction of PHN. Glomerular hemodynamic evaluation by
micropuncture in euvolemic rats with PHN revealed normal values for
nephron filtration rate (SNGFR), LpA and the glomerular hydrostatic
pressure gradient (iW) at day three, but by day five the whole kidney
GFR and SNGFR were decreased, P increased and LpA significantly
reduced. Glomerular binding of anti-Fx1A Ab increased from 38 gI7.6
x 1O glomeruli on day three to 52 g on day five. Immune complex
deposits evaluated by immunofluorescence and electron microscopy
appeared larger and were better defined on day five than on day three.
Epithelial foot process fusion was more extensive on day five than day
three. The onset of increased proteinuria correlated temporally with a
reduction in LpA on day five, which in turn correlated with increased
antibody binding, immune deposit accumulation and fusion of epithelial
cell foot processes.
Heymann nephritis (HN) in the rat has provided an experi-
mental model of membranous nephropathy which is similar in
morphologic and functional aspects to human membranous
glomerulopathy [1]. HN is induced by immunization of rats with
a crude fraction of renal tubular epithelium (Fx1A) in complete
Freund's adjuvant [2, 31. Intravenous injection of heterologous
antibody directed against the Fx1A antigen (passive Heymann
nephritis, PHN) produces a similar membranous nephropathy
[4, 5].
The immunopathogenesis of both the active and passive
forms of HN includes the reaction of antibodies with antigens
present in the glomeruli [6—8] with at least one antigenic system
present on the epithelial cell plasma membranes [9—12]. Im-
mune complex and other mechanisms continue to be considered
as well in the immunopathogenesis of this model [13]. The
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lesion has finely granular glomerular deposits of IgG and rat C3
by immunofluorescence (IF) and subepithelial electron—dense
deposits by electron microscopy (EM). Studies by Salant and
coworkers have characterized the time—course relationship
between antibody deposition and the appearance of proteinuria
in PHN [14]. These quantitative studies showed that antibody
fixation increased over five days after i.v. administration of
anti-Fx1A when abnormal proteinuria appeared. Studies by
Ichikawa et al demonstrated that both autologous and
heterologous HN were characterized by major alterations in
glomerular hemodynamics characterized by a decrease in
single—nephron glomerular filtration rate due to a major de-
crease in the glomerular ultrafiltration coefficient (LpA) [15].
Micropuncture studies in PHN by Ichikawa were performed
two weeks after the injection of the antibody. The im-
munopathologic and physiologic studies demonstrated that
PHN is characterized by two principal alterations: abnormal
proteinuria and low values of LpA. However, the difference in
temporal sequence of the previous studies precludes any cor-
relation between these two alterations in glomerular function.
One must remember that even though an association between
abnormal proteinuria and low LpA has been demonstrated in
other glomerular immune injury models [16—18], the necessity
for these two events to occur by the same mechanisms and in
the same temporal sequence has not been established. Abnor-
mal proteinuria requires an increase in the permeability of the
glomerular capillary to larger molecules, while low values of
LpA suggest a decrease in the conductance pathway for small
molecules such as water and electrolytes.
This study was designed to analyze the time—sequence rela-
tion between quantitative antibody deposition, morphologic
changes, appearance of abnormal proteinuria and the changes
in glomerular hemodynamic parameters in order to gain insights
into mechanisms. Balance, micropuncture, paired label radio-
isotope and histopathological studies were performed in rats
three and five days after the injection of anti-FxlA antibody
(Ab) and were compared to a normal control group. The
reduction in LpA correlated temporally with the onset of
abnormal proteinuria five days after anti-Fx 1A Ab administra-
tion. These events parallel the progression of the appearance of
immune deposits and glomerular morphology, as well as quan-
titative increases in antibody binding.
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Methods
Animals
Twenty—eight male Munich—Wistar rats provided either from
our colony which had been bred and housed at the San Diego
Veterans Administration Medical Center Animal Research Fa-
cility or from Simonsen lab (Gilroy, California, USA) were used
in this study. Animals were maintained on standard rat chow
and tap water ad libitum.
Preparation of the antibody and induction of PHN
PHN was induced by intravenous administration of rabbit
anti-rat FxIA antibody. The antibody was prepared by repeated
immunization of New Zealand White rabbits with 10 mg of
Fx1A prepared from Munich—Wistar rat kidneys incorporated
in complete Freund's adjuvant. The Fx1A was prepared by the
method Edgington, Glassock and Dixon [19], and is the lyophil-
ized, water washed sediment produced by 78,000 x g centrifu-
gation for one hour of the low—speed supernatant of a kidney
suspension prepared by passing cortical kidney slices through a
150-mesh stainless steel sieve. The initial low—speed centrifu-
gation removes tubular and glomerular fragments and other
fragments of renal basement membranes. The antisera were
harvested and absorbed three times with one—tenth volume of
packed Munich—Wistar rat, peripheral blood cells and used
either as whole serum or as gamma globulin fractions of the
whole serum prepared by precipitation in 50% saturated ammo-
nium sulfate. Three ml of the absorbed antibody or its equiva-
lent gamma globulin fraction were sufficient to induce abnormal
proteinuria in Munich—Wistar rats within five days after admin-
istration. Antibody was administered slowly as a single intra-
venous injection.
The binding of rabbit anti-FxlA antibody to the kidney and
other organs was quantitated using standard, paired—label ra-
dioisotope techniques [20] in which gamma globulin fractions of
the anti-Fx IA antibody and control rabbit serum were radiola-
beled [21] with 1251 and ''i, respectively. The usual dose of 93
mg of anti-Fx1A gamma globulin containing the paired label
mixture (greater than 96% precipitable in 10% trichloroacetic
acid) was administered to six rats and the kidneys from groups
of three rats each obtained on days three and five after
extensive arterial perfusion with normal saline via the right
ventricle and abdominal aorta. In addition to whole organ and
washed organ homogenate uptakes, glomerular precipitations
were obtained by differential sieving [221, the radioactivity
determined and the number of glomeruli recovered assessed by
replicate counts of 20 pi samples. The specific uptake was
calculated in micrograms per whole organ or per gram of tissue
[18, 20], and in the kidney were additionally expressed per 7.6
x l0 glomeruli, the number of glomeruli assumed to be present
in two kidneys [23, 24].
Balance studies
To evaluate the effect of anti-FxlA antibody administration
on rat weight and proteinuria 10 rats underwent metabolic
studies. Five rats received anti-Fx1A antibody while five con-
trol rats received an equivalent amount of non-specific rabbit
gamma globulin. Rats were placed separately in metabolic
cages one day prior to the injection of either anti-Fx1A Ab or
rabbit IgG and remained thereafter for up to six days after the
injection. During this period rats had free access to powdered
rat chow and tap water. Twenty—four hour urines were col-
lected for at least nine consecutive days and urinary protein
measured by sulfosalicylic acid method [25].Body weight was
determined daily. On day nine rats were anesthetized with
Brevital, and kidney tissue was harvested for histopathotogic
studies. To correlate with the time sequence of the parallel
micropuncture studies, we analyzed the urine protein excretion
on day 5.3. This was necessary due to the fact that the actual
time of micropuncture did not exactly correlate with the 24-
hour urine collection schedules.
Micropuncture studies
The impact of anti-Fx IA injection on glomerular hemody-
namics was analyzed in three different groups of rats. Group I
(C) which served as control, was constituted by seven normal
untreated rats of the same approximate weight as groups II and
III. Six animals evaluated three days after the infusion of
anti-Fx1A Ab constituted Group II. Group III (Gill) (N=6) was
evaluated on day five after the infusion of anti-Fx1A Ab.
Rats were anesthetized with mactin (lOOmg/kp i.p.) and
placed on a temperature—regulated micropuncture table. Rats
were surgically prepared according to procedures described
previously [26]. Briefly, following placement of a tracheostomy,
the jugular vein, femoral artery and bladder were catheterized
with PE-50 tubing; the left kidney was exposed through a
midline incision and placed in a lucite holder after gently
dissecting the surrounding tissue. The kidney cup surrounding
the kidney was packed with cotton and 2% agar and the surface
was covered with NaCI-NaHCO3 solution maintained at 37°C.
The left ureter was catheterized with PE-lO. The femoral artery
catheter was used for periodic blood sampling and monitoring
of the mean arterial pressure (MAP) with a transducer (Model
P23db, Statham Instruments, Gould Division Inc., Hato Rey,
Puerto Rico) and recorded on a Statham chart recorder. The
volume status of each rat during micropuncture was maintained
using a euvolemic protocol by infusing 1% body weight (body
wt) donor plasma over a one hour period followed thereafter by
0,15% body wt donor plasma per hour [27, 28]. Rats also
received an infusion of isotonic NaC1-NaHCO3 containing [3H]
inulin at a rate of 100 pCi./hr in a volume of 1.5 ml for one hour
prior to and throughout the micropuncture period.
After the inulin and plasma had been infused for one hour
measurements of hydrostatic pressures in efferent arterioles
(HPE), glomerular capillaries (PG), and Bowman's space (PBS)
were obtained as previously described [29] with a servo-nulling
device with I to 3 m tip pipettes. Efferent arteriolar protein
concentration (CE) was evaluated in samples from direct punc-
ture (13 to 16 m tip pipettes) of at least three efferent arterioles
(star vessel). Afferent protein concentration (CJ was deter-
mined from arterial blood specimens obtained concurrently
from the femoral artery catheter for micro-protein analysis. To
determine absolute proximal reabsorption (APR) and single
nephron glomerular filtration rate (SNGFR) a 1 to 3 m tip
pipette filled with isotonic NaCI-NaHCO3 slightly stained with
FD and C green (Allied Chemical, Specialty Chemicals Div.
Morristown, New Jersey, USA) was inserted into a proximal
convolution to allow visualization of the late portion of the
proximal tubule. After placement of an oil block, fluid was
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collected over a period of 2-'/2minutes, five nephrons from each
animal. Timed urine samples were collected from left
(micropunctured) and right kidneys for determination of urinary
flow rate and inulin activity. Urine collections were bracketed
by arterial blood collections in order to determine [3H] inulin
concentration and hematocrit.
At the conclusion of the micropuncture measurements, a
superficial wedge was taken from the left kidney during normal
blood perfusion and instantly minced in cold 2% Karnovsky's
fixative at pH 7.4 for electron microscopic analysis. While the
wedge was being minced for electron microscopy, both kidneys
were removed, bisected longitudinally and half snap frozen in
liquid nitrogen for immunofluorescence and the other half
placed in Bouin's fixative for light microscopy. The histologic,
immunofluorescent, and electron microscopic techniques used
have been previously described in studies from our laboratories
[18, 30, 31]. Immunofluorescence studies employed fluoresce-
mated antisera specific for goat IgG, rat IgG, and rat C3.
The light microscopic studies were compared to those in
unmanipulated control rats by measuring several parameters in
a qualitative and semi-quantitative fashion. The number of
polymorphonuclear leukocytes (PMN) were counted in at least
20 glomeruli per kidney. The degree of hypercellularity and
apparent GBM thickening were graded on a 0-4 + scale (0 being
indistinguishable from normal). The degree of interstitial infil-
tration and tubular abnormality was noted and graded in terms
of extent of distribution as well as the overall severity on a 0-4 +
scale. The intensity and extent of immunofluorescence staining
was assessed semi-quantitatively on a 0-4+ scale based on the
amount of deposit present, and further characterized by its
anatomic localization and pattern, in which linear or granular
were used in accord with continuous or interrupted distribution.
On electron microscopy, the localization and quantity of elec-
tron dense deposits were noted and abnormalities in the glomer-
ular basement membrane, endothelial and epithelial cells, and
mesangial areas noted. Tissues from experimental animals were
single blinded such that the author who interpreted morphologic
changes was not aware of the experimental group which was
analyzed.
Analytic methods
[3H] Inulin activity in plasma, urine and tubular fluid was
monitored on a model 2425 Packard liquid scintillation counter
(Packard Instrument Co; Downers Grove Illinois, USA). All
protein collections were analyzed by a microadaptation of the
method of Lowry et al [321 as previously described by this
laboratory [26, 29].
The volume of fluid collected from an individual tubule was
estimated from the length of the fluid column in a constant bore
capillary tube of known internal diameter.
Calculations
Single nephron glomerular filtration rate was calculated by
SNGFR=TFIP1 x YF, where TF/P1 and VF refer to transtubu-
lar [3H] inulin concentration ratio and tubule fluid flow rate,
respectively.
The calculations of superficial single nephron filtration frac-
tion (SNFF), nephron plasma flow (SNPF), nephron blood flow
(SNBF), afferent anteriolar resistance (AR) and efferent arteri-
olar resistance (ER) was as previously described [18, 26, 29,
30].
Oncotic pressure (ii) was determined from the protein con-
centration by the method of Landis and Pappenheimer [33]. The
specific modifications to the equations describing these relation-
ships have been shown in previous publications from this
laboratory [26, 29]. The SNFGR is a product of the mean
effective filtration pressure (EFP) and the glomerular ultrafiltra-
tion coefficient (LpA) (SNGFR=EFPx LpA). The EFP can be
defined as follows:
EFP = P-it.
it rises along the length of the glomerular capillary (x*) (nor-
malized to a unit length) as a result of the formation of
glomerular ultrafiltrate and the resultant increase in protein
concentration (C). The EFP is defined as:
EFP= I (P_it)dx*
Jo
Changes in SNPF modify the EFP profile by affecting the rate of
concentration of protein and it along x". From the EFP profile
thereby generated, LpA is known. This method has been
described in detail in recent publications from our laboratory
[26, 29].
Statistical analysis
Statistical significance between groups of animals was eval-
uated by unpaired Student's t-test. When several measurements
were obtained from a rat (SNGFR, SNBF, P0, P) each of
these values was entered separately and analyzed by unpaired
I-test [34, 35]. Statistical significance was defined as P < 0.05.
Results are expressed as means SEM.
Results
Balance studies
Figure 1 shows the time—course of changes in protein excre-
tion in rats injected with normal rabbit serum and anti-FxlA
Ab. There were minor changes in urinary protein excretion
from 5± 1.3 mg124 hr pretreatment to 8.4± 1.1 mg124 hr, seven
days after injecting normal rabbit serum into control rats. It
should be stated that micropuncture studies were performed at
a time period corresponding to the end of the fifth day, 24-hour
urine collection. In micropuncture rats, urines were collected
for the first 16 to 18 hours of the fifth day with no increase in
urinary protein excretion detected in PHN rats. This finding
suggests that protein excretion was increasing just at the time of
micropuncture and that actual protein excretion was probably
best reflected by a combination of day five and day six values
(Fig. 1). Urinary protein excretion increased significantly above
day four values (P < 0.05) in all animals on day 5.3. We
analyzed day 5.3 by adding day five and day six urinary
excretion values in proportion to their contribution (0.67 [day 5]
+ 0.33 [day 6]). This extrapolation was performed to correlate
the urinary protein excretion values from the time course group
with the micropuncture animals. The paired control value prior
to anti-Fx1A Ab injection with 5.1 0.6 mg proteinl24 hr (N=5)
compared to the value at time of micropuncture of 19.1 3.7mg
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Fig. 1. The profile of urinary protein excretion in rats before treatment
and as a time course after injection with normal rabbit serum (open
circles) and anti-FxIA antibody (closed circles). Data are expressed as
mg protein excreted per 24 hours. * P < 0.05 when normal rabbit serum
controls are compared with the anti-Fx1A injected rats on the same
day. P < 0.02 when paired comparisons are made between control
protein excretion (pre-injection of anti-Fx1A antibody) and protein
excretion at time of micropuncture, day 5.3 (actual micropuncture
studies were performed in a parallel group of rats).
protein/24 hr (P < 0.02). Following day five, a steady increase
in protein excretion was observed of up to 15 times the
pretreatment values. Rabbit serum injected rats followed a
normal trend for body weight gain of 2 to 3 g per day (pretreat-
ment, 221 4 vs. 230 II g. body wt on day 7, NS, N=5)
similar to previous data derived from our rat colony [33].
Anti-FxlA Ab injected rats demonstrated a major decrease in
body weight the day after the injection (pretreatment, 230 6
vs. 209± 4 g. body wt on day I, P < 0.05, N=5) which was
followed by a trend for an increase in weight, however seven
days after antibody injection most rats remained below their
initial pretreatment weight (230 6 vs. 224 15 g. body wt on
day 7, NS, N=5).
Micropuncture studies
Table I depicts the values for MAP, hematocrit, whole
kidney GFR and the values for the different determinants of
glomerular hemodynamics in Group I (normal control rats).
Group 11(3 days after injection of anti-FxIA Ab) and Group III
(5 days after injection of anti-Fx1A Ab). When one compares
Groups I and II significant differences could only be demon-
strated for MAP, AR, SNFF and EFPE. Lower values for MAP
were observed in Group II which probably explains the lower
values of AR based on autoregulatory phenomenon since
similar values for SNPF and SNBF were found in both groups.
LpA values in Group II were not different from control (I) (Fig.
2) and very similar to previous values found in the literature for
normal euvolemic rats [271. However one must consider that
LpA values in control rats were minimum estimates due to
conditions of filtration pressure equilibrium (EFP not different
from zero).
When one compares rats five days after antibody injection
(Group III) to the control group, a completely different pattern
appears. In this case, significant differences could be demon-
strated for all parameters except Hct, PBS, HPE, SNBF, r A
and ER. With respect to SNBF, although these values were
numerically higher, statistical significance was not achieved due
to numerical scatter. Five days after the injection of anti-Fx1A
Ab decreases in whole kidney, GFR and SNGFR could be
demonstrated. The decrease in SNGFR was not secondary to a
decrease in plasma flow since this value was higher than in
control rats, but due to a major decrease in the ultrafiltration
coefficient (LpA) (Fig. 2). The decrease in LpA was of such
magnitude that the concurrent major increase in G or P was
not sufficient to maintain SNGFR values equal to the control
level. Associated with this decrease in SNGFR, significantly
lower values for APR were demonstrated which could be
related either to an anti-Fx 1 A Ab effect on tubular reabsorption
or to the phenomenon of glomerulotubular balance.
When both groups of anti-Fx1A injected rats were compared,
significant differences were observed for critical pressures (PG
and z P) and the glomerular ultrafiltration coefficient with
values in the five day group for LpA approximately 40% of the
three day values. Therefore the temporal sequence of changes
in SNGFR, P and LpA paralleled the observed changes in
protein excretion in that values remained essentially normal at
day three after anti-FxIA antibody administration, but changed
significantly by day five.
Morphologic, immunofluorescence and electron microscopic
evaluation of renal tissue
The morphologic studies revealed a considerable degree of
consistency in the changes observed between the two groups of
rats and among glomeruli within various levels of the cortex. By
light microscopy, the glomeruli appeared to be essentially
normal at both days three and five, with no increase in poly-
morphonuclear leukocytes over the usual 0 to 2 per glomerular
cross—section identified in unmanipulated control rats of this
strain (Fig. 3). No increase in glomerular cellularity was found.
The glomerular basement membranes did not appear altered,
although the glomerular capillary walls appeared somewhat
more irregular than usual, perhaps related to subtle changes in
the cytoplasm of the glomerular epithelial cells. Of interest, a
small but definite increase in the number of mononuclear cells
was observed focally in the renal interstitium surrounding renal
tubules, particularly by day five (Fig. 4). No frank destruction
of renal tubular cells was evident. The brush border areas of the
proximal tubules appeared to be reasonably well retained,
although in areas some irregularity of the brush border areas
was observed, perhaps to a slightly greater extent than seen in
control sections, No inflammatory cells were recognized within
the lumens of renal tubules. The renal vasculature appeared to
be within normal limits.
By immunofluorescence microscopy, striking deposits of
rabbit IgG were observed in areas within the glomeruli in a
finely granular, nearly continuous pattern outlining the periph-
eral glomerular capillary—walls (Fig. 4). A subtle change in the
pattern of deposit was apparent between days three and five, in
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Table 1. Glomerular hemodynamics and proximal tubular reabsorption in control rats and in rats three and
five days after the administration of anti-FxIA
AR ER
LpA
MAP
mm HCT
P PBSP HPE SNGFRSNPF ITA ITE
mm mm
dynes.
sec
EFPA EFPE
mm
sec' GFR APR
mm ml n!
Hg % Hg nl.min' Hg cm5 SNFF Hg Hg' min' min'
Group I l23' 49 50.6 15.8 34.8 19.5 40.3 132 262 19.7 34.8 22,8 11.7 0.31 15.1 0.0 6.8 0.111 1.03 19.5
Euvolemic ±1 ±1 ±0.9 ±0.7 ±0.6 ±1.0 ±1.6 ±9 ±19 ±0.8 ±1.0 ±2.2 ±1.1 ±0.02 ±1.0 ±1.4 ±1.2 ±0.013 ±0.06 ±0.5
Control(N = 8)
Group II 91" 47 48.8 14.8 34.0 18.0 36.6 144 273 19.5 30.6" 127b 10.5 0.26" 14.4 3.3 8.2 0.078" 0.92 16.3
3 day ±2 ±1 ±1.5 ±1.0 ±0.5 ±1.6 ±2.8 ±13 ±22 ±0.7 ±0.8 ±1.0 ±0.8 ±0.01 ±0.7 ±0.8 ±1.0 ±0.007 ±0.06 ±2.1
anti-Fx lA
(N = 6)
Group Ill 108c, 46 56.7" 16.0 40.7 18.6 33,4c 173 321 19.8 28.0 14.lc 11.3 020c.d 209c.d 12.7 169c,d 0033c.d 0.86c 15.2c
5 day ±5 ±1 ±1.4 ±0.6 ±1.2 ±1.7 ±2.7 ±25 ±44 ±0.8 ±0.6 ±2.4 ±1.3 ±0.02 ±1.1 ±1.6 ±1.3 ±0.002 ±0.05 ±1.8
anti-Fx1A(N = 6)
a All values are expressed as the mean ± SEM
b P < 0.05 Group I vs. Group II, by unpaired Student's t-test
P < 0.05 Group I vs. Group III, by unpaired Student's t-test
d P < 0.05 Group II vs. Group III, by unpaired Student's t-test
that the individual granular deposits appeared to be somewhat
more discrete and better defined in day five samples. Little or
no rat IgG was observed on day three, and only equivocal to
trace scattered deposits were present on day five. Rat C3 was
present in a diffuse irregular pattern outlining the peripheral
glomerular capillary loops on both days three and five. The
individual deposit appeared to be larger and better defined on
day five than on day three, particularly in sections stained for
rat C3 (Fig. 5). In addition to the glomerular deposits, rabbit
IgG (in some instances accompanied with rat C3) was observed
in a granular pattern in the TBM and/or basilar areas of renal
tubular cells of 10 to 30% of tubules (Fig. 4). The majority of the
tubules involved appeared to be proximal tubules. The granular
localization was somewhat more prominent at day five than at
day three. In addition, deposits of IgG were observed along the
brush borders of the proximal tubular cells with an increase in
both the numbers of tubules involved and the intensity of
staining between days three and five, so that by day five, 30 to
60% of the tubules had such deposits. Occasionally, C3 was
observed within the tubular lumens as well.
The impression of increasing deposits observed by im-
munofluorescence microscopy was confirmed on electron mi-
croscopic study (Fig. 6). On day three, little glomerular abnor-
mality was observed aside from small, scattered, and usually
discrete electron—dense deposits occurring along the subepithe-
hal aspect of the glomerular basement membrane. Epithelial
cell foot processes in the areas of the deposit were sometimes
fused (Fig. 6A). The deposits were both under epithelial cell
foot processes and in areas of slit—pore membranes. By day
five, the electron dense material was more prominent and in
areas was almost contiguous, giving rise to a somewhat seg-
mental appearance (Fig. 6B). These areas of segmental deposit
were almost always associated with epithelial cell foot process
fusion. The electron dense deposits were not associated with
inflammatory cells or abnormalities in endothelial cells.
Glomerular basement membranes did not appear altered. Over-
all, on both days three and five the electron dense deposits were
relatively scattered, and even by day five, only 15 to 30% of the
peripheral glomerular capillary—wall appeared to be occupied
with deposits in the two—dimensional view afforded by the
electron microscopic section.
Analysis of binding of anti-FxIA antibody
Quantitative glomerular fixation of anti-Fx 1 A antibody rose
from 38.0 ± 0.9 at three days to 51.8 ± 4.2 xg/7.6 x l0
glomeruli at five days. The glomerular binding represented 31
and 36% of the total kidney binding at days three and five,
respectively. At three days, the amount of anti-Fx1A antibody
found per gram of whole lung, spleen, liver, heart, and testes
was 24, 24, 9, 10, and 7%, respectively, of that found in the
whole kidney. By day five, the binding to extrarenal organs had
decreased to 9, 8, 5, 4, and 5% of that in the kidney. The amount
of the labeled anti-Fx1A antibody specifically bound in jig per
gram of lung, spleen, liver, heart, and testes was 5.4, 5.6, 2.3,
0.5, and 3.2 on day three and 1.9, 2.8, 1.3, 0.5, and 1.0 on day
five.
Discussion
The two major renal events which have been observed in
association with glomerular immune injury are the onset of
abnormal proteinuria and a major reduction in the glomerular
ultrafiltration coefficient [15—18]. In PHN, it has been observed
that the onset of increased proteinuria occurs approximately
five days after the administration of the heterologous antibody
[5, 141, implying that this period of time is required for either
critical quantities of antibody to be deposited within the glomer-
ular capillary wall or that some later morphologic event takes
place which permits increased passage of macromolecules
across the capillary wall. This study demonstrates that reduc-
tions in LpA, the second, probably quite different membrane
abnormality characteristic of immune injury, also requires at
least five days to be expressed, therefore approximately coin-
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Glomerular hydrostatic
pressure gradient (P)
Glomerular ultrafiltration
coefficient (LPA)
ciding with the onset of abnormal proteinuria. This study was
designed to examine glomerular hemodynamics and morphol-
ogy prior to onset of proteinuria (day 3) and at the first
observation of abnormal proteinuria at day five. There is in fact
no logical a priori reason dictating that a reduction in LpA and
increased leak of macromolecules should be coincident events,
since the limiting barriers for water and small solute movement
and molecules as large as albumin are likely quite different.
Regardless of the specific mechanisms which produce the two
characteristic membrane abnormalities, five days after initial
exposure to heterologous antibody are required for the simul-
taneous expression of reduced LpA and increased proteinuria.
Since these abnormalities in renal function were not present at
three days in spite of significant antibody deposition, morpho-
logic differences were assessed utilizing electron microscopy
and immunofluorescence.
Micropuncture analysis of kidney function prior to the onset
of abnormal proteinuria revealed a basically normal hemody-
namic pattern except for reductions in systemic blood pressure,
afferent resistance and filtration fraction. The mechanism re-
sponsible for the lowering of systemic blood pressure is un-
known. This decrease in MAP could be related either to
aberrations in the nutritional and volume status of the animals
as evidenced by a 10% reduction in weight the day after
administration of the antibody or to a nonspecific effect of the
Fig. 2. The alterations in glomerular hemodynamics after
anti-FxJA antibody induced Heymann nephritis of 3 or 5 days
duration are compared to euvolemic controls. tp < 0.05
euvolemic control versus 5 day Heymann nephritis. tP < 0.05 3
day Heymann nephritis compared to 5 day Heymann nephritis
antibody on the systemic vasculature. Indeed, Salant et al have
demonstrated that injection of anti-FxlA IgG was associated
with major vascular permeability changes as evidenced by
increases in hematocrit during the first two hours after the
injection [36]. Therefore it is possible that these changes in
vascular permeability, although not evident through changes in
hematocrit, might be responsible for this modest decrease in
systemic blood pressure. Absence of blood pressure measure-
ments in previous studies in the literature preclude us from
discerning between a specific vascular action of our antibody
and a common anti-FxIA Ab reaction [14, 36, 37].
The present studies confirmed the slow and progressive
binding of anti-Fx IA in rat glomeruli in vivo previously re-
ported [14]. About 70% of the antibody present at day five had
already bound by day three. The quantitative increase in
anti-Fx1A antibody deposition between day three and five was
supported by immunofluorescent and electron microscopic ev-
idence of increasing immune deposits in the kidneys. The slow
tempo of binding and associated mediator activation may con-
tribute to the relative lack of leukocyte infiltration in this model
which contrasts with the abrupt onset of polymorphonu-
clear—leukocyte—associated glomerular dysfunction that charac-
terizes the rapid binding of antiglomerular basement—membrane
antibody reactive with another fixed glomerular antigen [18,
30]. The site of antibody fixation (subepithelial versus suben-
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Fig. 3. By light microscopy essentially normal appearing glomeruli were present at 3 days (A) and 5 days (B), as demonstrated here in thin sections
from plastic embedded material. Original magnification X 400.
Fig. 4. Irregularly—sized granular deposits of IgG (arrows) were present outlining the glomerular capillary walls in a rat five days after
administration of anti-FxIA Ab. Original magnification X 400. B. Distinct granular deposits of IgG were observed in the tubular basement
membrane and basal areas (arrows) of renal tubules focally in rats at three days (as well as 5 days) after receipt of anti-Fx1A Ab. Staining of the
brush border areas of these tubules (hatched arrows) frequently, but not always, was identifiable in tubules containing basilar deposits. Original
magnification X 400. C. By light microscopy a small increase in mononuclear inflammatory cells (arrows) was observed very focally within the
interstitium in rats five days after anti-Fx1A Ab administration. Original magnification X 250.
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Fig. 5. A subtle increase in size as well as coarsening of the immune deposits was observed between days three (A) and five (B) after anti-FxIA
antibody administration, as demonstrated in sections stained for rat C3. Original magnification X 400. Magnification of the enlarged areas is an
additional 2.9 times.
dothelial) has also been suggested to contribute to the evolution
of the inflammatory change in the glomerulus [14, 38, 39]. The
amount of glomerular antibody fixation associated with in-
creased proteinuria at day five in the current study using a
rabbit anti-Fx1A antibody in the Munich—Wistar rat was simi-
lar, but somewhat less than that reported for goat anti-FxIA
antibody used in the Charles River rat [14], being about 145 g
compared to 200 g per total kidney. Of interest, a gamma-i
fraction of the goat anti-Fx1A antibody did produce abnormal
proteinuria at almost the same glomerular binding, that is, 60 g
[37], as found in the current study.
The quantitation of anti-Fx1A binding within the kidney is
complicated by the presence of both glomerular and tubular
reactive antigen—antibody systems. Anti-Fx1A antibodies can
clearly lead to tubular damage in the active model of
Heymann's nephritis [1, 40—42] and in the current study mini-
mal histologic change was observed in the interstitium with a
significant decrease in APR paralleling the reduction in SNGFR
at day five. In ongoing studies using another rabbit anti-Fx1A
antibody, a complement—dependent reduction in absolute tubu-
lar reabsorption was observed following the administration of
anti-Fx1A antibody [43]. If one assumes that the 70% or so of
Fig. 6. The change in immune deposit accumulation identified as electron dense deposits on electron microscopy, with or without associated
foot—process fusion, are demonstrated at three days (A) and five days (B) after anti-FxJA antibody administration. At three days, the electron
dense deposits were scattered and generally small (A, upper panel), with only occasional areas in which the deposits appeared to join together (A,
lower panel), taking on a somewhat segmental appearance. These larger segmental areas of deposit were often associated with foot process fusion.
The types of changes seen were similar at day five, with an increase in the numbers of electron dense deposits and an increase in the areas in which
the deposits appeared to have aggregated and developed a segmental appearance, with associated foot—process fusion (B, lower panel). Even at
five days, portions of most glomerular loops remained relatively free of deposits and foot process fusion. Original magnifications: A, X 5376 and
B, 8280 middle panels; the upper and lower panels of both A and B X 30,000.
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anti-Fx IA antibody bound in the total kidney and not found in
the glomerular fraction represented tubular binding, it could be
estimated that roughly 92 j.g of this particular antibody found
was not associated with demonstrable and only minimal his-
tologic abnormality. This contrasts with the more impressive,
albeit focal, tubulointerstitial nephritis inducible by passive
transfer of a calculated 170 jig of anti-tubular basement mem-
brane antibody in the rat [441.
Within five days, all PHN rats developed abnormal protein-
uria which was persistent with a clearly increasing pattern
thereafter. Associated with the onset of abnormal proteinuria,
major functional changes became obvious at the whole kidney
and glomerular level. GFR decreased approximately 17% and a
proportional decrease in SNGFR was detected. The decrease in
SNGFR was the result of a major reduction in LpA which was
not compensated by increases either in P0, P or SNPF. These
changes in SNGFR, LpA and PG and P are nearly identical to
values described by Ichikawa et al [15] who examined a similar
PHN model two weeks after the injection of anti-Fx1A Ab. The
specific mechanism responsible for the decrease in LpA is
unknown, however different hypotheses can be advanced. LpA
represents the product of the hydraulic conductivity of the
glomerular membrane (Lp) and the filtering surface area (A);
low values for LpA could be related to decreases in either one
or both of these parameters. Previous micropuncture studies on
antiglomerular basement membrane (GBM) nephntis have also
shown low values for LpA [16—18] and the findings seem
consistent in models studied to date [45]. Previous studies from
this laboratory in an acute (1 hr) AGBM-Ab immune injury
model have demonstrated that low values of LpA are associated
with C3 fixation and the presence of leukocyte infiltration and
attachment to the glomerular wall [18, 30]. This reduction in
LpA was also prevented by leukocyte depletion with the
particular anti-GBM Ab used [46]. A major role for leukocyte
infiltration in decreasing the glomerular ultrafiltration coeffi-
cient is not a possibility in PHN. As demonstrated with both
light and electron microscopic evaluation from this study and
from previous studies in the literature [1, 5—7, 14, 36, 37],
membranous nephropathy is characterized by the absence of
inflammatory cell infiltration with capillary loops remaining
basically patent during most stages of this disease, therefore
eliminating this explanation for the decrease in LpA.
A second possibility which might explain the decrease in LpA
relates to the effects of antibody bound to the glomerular
capillary wall either secondary to the immune deposit accumu-
lation or more likely via direct or indirect effects on glomerular
epithelial foot processes. The evolution of the lesion indicates
increasing quantitative antibody—binding, immune deposit for-
mation and epithelial foot—process fusion between day three
and day five. It is reasonable to speculate that the numerous
electron—dense deposits found in the subepithelial space by day
five, as well as scanning electron microscopy identified alter-
ations in GBM of patients with membranous nephropathy [47],
could reduce or alter the effective surface area for filtration and
thereby decrease LpA. Probably more important is the glomer-
ular epithelial damage and foot process fusion approaching 30%
of the mean glomerular circumference by day five. The immune
deposit formation and the epithelial cell foot—process fusion
may have common etiologies, induced by antibodies reacting
with antigens present on the epithelial cell membrane [9—11].
The alteration in epithelial cell architecture is not an imme-
diate consequence of antibody fixation, but rather requires
some time for completion of these architectural changes. It is
intriguing to postulate that these events may relate to the
"capping and shedding" of cell surface—antibody complexes, as
proposed by Matsuo and coworkers for deposits in the zona
pellucida [48]. Chlorpromazine is suggested to inhibit a possibly
similar phenomenon in glomerular epithelial cells reacted with
anti-Fx1A antibody [11]. If antigens critical to the electronega-
tive surface charge of the epithelial cell migrate after antibody
fixation to coalesce before "shedding", the cell surface may
become depleted of cell surface charges necessary to maintain
the complex tertiary structure of the epithelial foot process, and
fusion of epithelial foot processes to the GBM may result. Also,
the "capping and shedding" phenomenon involved in the
aggregation of complex material may require cytoskeletal rear-
rangement which could also contribute to morphologic changes
in the epithelial cell foot—process. Such fusion may contribute
to reductions in the effective hydraulic conductivity and/or
outer surface area of the glomerular membrane.
Complement activation also plays a role in the development
of proteinuria in PHN [36]. Recently data have shown that in
both autologous and heterologous HN, the onset of increased
proteinuria depends on complement activation with evidence
suggesting that generation of CSb-9 complex or membrane
attack complex may contribute to the injury [37, 49, 50]. It is
possible that the membrane attack complex is somehow respon-
sible for lowering LpA directly but evidence has yet to be
provided. Recent preliminary studies from this laboratory have
supported the concept that complement activation is involved
in the reduction in LpA observed in PHN on day five. Treat-
ment of rats with cobra venom factor resulted in complement
depletion, as indexed by serum C3 levels, and this treatment
resulted in significant, but not complete amelioration of the
expected reduction in LpA five days after the administration of
anti-FxlA Ab [43].
A third mechanism which could be postulated to explain the
decrease in LpA relates to the generation of vasoactive sub-
stances in relation to the glomerular damage. Studies from this
laboratory and by Schor, Ichikawa and Brenner have shown
that a great number of vasoactive substances, including anglo-
tensin II, prostaglandins, etc., can directly or indirectly de-
crease LpA [51]. Lianos, Andres and Dunn have shown that in
nephrotoxic serum immune injury model an increased level of
prostaglandins and thromboxanes could be directly related to
glomerular injury [52]; however, the possible dependence of the
substances on the presence of leukocyte and platelet infiltration
should be kept in mind. It is possible that in this model, binding
of antibody to the glomerular capillary could trigger the gener-
ation of vasoactive compounds which might be responsible,
through mesangial contraction, for lowering LpA either directly
or via activation of the complement system. Yoshioka and
coworkers recently suggested that in a model of PHN, manip-
ulation of P by the infusion of acetylcholine and angiotensin II
induced parallel changes in protein excretion and the
transglomerular passage of neutral dextrans (20 to 60 A).
Increases in AP in this model of PHN may enhance the absolute
protein excretion observed [53]. However, preliminary results
from this laboratory suggest that administration of angiotensin
converting enzyme—inhibitor does not prevent the reduction in
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LpA in this model of PHN [54].The studies indicate that there
is a temporal relationship between the onset of proteinuria and
alteration in LpA in PHN associated with increased antibody
binding, immune deposit accumulation and epithelial foot proc-
ess fusion. Preliminary results suggest that the events respon-
sible for these two antibody induced alterations in glomerular
function may be partially separable on the basis of complement
dependence.
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